166 related articles for article (PubMed ID: 34705295)
21. Primary cutaneous anaplastic large cell lymphoma.
Brown RA; Fernandez-Pol S; Kim J
J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276
[TBL] [Abstract][Full Text] [Related]
22.
Wang M; Kibbi N; Ring N; Siddon A; Foss F; Totonchy M
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570354
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous anaplastic large cell lymphoma occurring in an atopic dermatitis patient: a case report with review of the literature with emphasis on their association.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2014; 7(4):1735-41. PubMed ID: 24817972
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.
Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC
Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363
[TBL] [Abstract][Full Text] [Related]
25. Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior.
Gerbe A; Alame M; Dereure O; Gonzalez S; Durand L; Tempier A; De Oliveira L; Tourneret A; Costes-Martineau V; Cacheux V; Szablewski V
Virchows Arch; 2019 Aug; 475(2):163-174. PubMed ID: 30953147
[TBL] [Abstract][Full Text] [Related]
26. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding.
Al-Rohil RN; Torres-Cabala CA; Patel A; Tetzlaff MT; Ivan D; Nagarajan P; Curry JL; Miranda RN; Duvic M; Prieto VG; Aung PP
J Cutan Pathol; 2016 Dec; 43(12):1161-1166. PubMed ID: 27531242
[TBL] [Abstract][Full Text] [Related]
27. Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations.
Grandhi A; Boros AL; Berardo N; Reich RF; Freedman PD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):e41-7. PubMed ID: 22940020
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia.
Lin JH; Lee JY
J Cutan Pathol; 2004 Jul; 31(6):458-61. PubMed ID: 15186435
[TBL] [Abstract][Full Text] [Related]
29. [Primary cutaneous CD30-positive anaplastic large cell lymphoma].
Shi Q; Xu X; Yin H; Zhou X; Zhang T; Sun G; Mikihiro S; Qian B
Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):97-100. PubMed ID: 11866962
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
Mingola P; Alshomrani A; Greiner T
J Hematop; 2024 Mar; 17(1):23-26. PubMed ID: 38376721
[TBL] [Abstract][Full Text] [Related]
31. Cytomorphologic features of primary anaplastic large cell lymphoma of the psoas muscle: a case report and literature review.
Recavarren RA; Yang J
Diagn Cytopathol; 2010 Mar; 38(3):208-12. PubMed ID: 19760764
[TBL] [Abstract][Full Text] [Related]
32. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
33. A primary systemic ALCL present initially as cutaneous localized skin lesions: report of an unusual case.
ALSayyah A; AlHumidi A
Am J Dermatopathol; 2015 Jan; 37(1):e12-4. PubMed ID: 24752216
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic large cell lymphoma in a human immunodeficiency virus-positive patient with cytologic findings in bladder wash: a case report.
Proca DM; De Renne L; Marsh WL; Keyhani-Rofagha S
Acta Cytol; 2008; 52(1):83-6. PubMed ID: 18323280
[TBL] [Abstract][Full Text] [Related]
35. CD30 positive anaplastic large-cell lymphoma mimicking Langerhans cell histiocytosis.
Ezra N; Van Dyke GS; Binder SW
J Cutan Pathol; 2010 Jul; 37(7):787-92. PubMed ID: 19817947
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
37. Myxoid variant of primary cutaneous anaplastic large cell lymphoma: First 2 cases.
Fernandez-Flores A; Eginli A; Cassarino DS
J Cutan Pathol; 2017 Sep; 44(9):772-775. PubMed ID: 28626950
[TBL] [Abstract][Full Text] [Related]
38. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
[TBL] [Abstract][Full Text] [Related]
39. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Gru AA; Voorhess PJ
Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
[TBL] [Abstract][Full Text] [Related]
40. Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile.
Kwatra KS; Paul PAM; Calton N; John JM; Cotelingam JD
South Asian J Cancer; 2017; 6(3):129-131. PubMed ID: 28975123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
